Table 4.
Bivariate and Multivariable Analysis of Influencing Factors Associated with Survival of CC Patients
| Factors | Crude HR (95% CI) | p-value | Adjusted HR (95% CI) | p-value |
|---|---|---|---|---|
| Age at diagnosis | <0.001 | 0.004 | ||
| <30 | 1.42 (0.85 - 2.39) | 1.53 (0.91 - 2.58) | ||
| 30-49 | 1 | 1 | ||
| 50-59 | 1.08 (0.92 - 1.26) | 0.98 (0.83 - 1.14) | ||
| ≥60 | 1.57 (1.37 - 1.83) | 1.25 (1.07 - 1.46) | ||
| Health insurance | <0.001 | <0.001 | ||
| Civil servant medical benefit scheme | 1 | 1 | ||
| Social security scheme | 2.44 (1.70 - 3.50) | 3.84 (2.66 - 5.54) | ||
| Universal health coverage scheme | 5.22 (4.29 - 6.35) | 6.26 (5.13 - 7.64) | ||
| Histopathology | 0.077 | 0.009 | ||
| Squamous cell carcinoma | 1 | 1 | ||
| Adenocarcinoma | 1.09 (0.93 - 1.28) | 1.16 (0.99 - 1.36) | ||
| Malignant neoplasms | 1.34 (1.06 - 1.69) | 1.36 (1.07 - 1.74) | ||
| Others | 1.16 (0.91 - 1.48) | 1.31 (1.03 - 1.68) | ||
| Treatment | <0.001 | <0.001 | ||
| Surgery | 1 | 1 | ||
| Concurrent chemoradiotherapy | 3.76 (2.64 - 5.36) | 3.41 (2.39 - 4.86) | ||
| Radiotherapy | 5.48 (3.86 - 7.78) | 5.46 (3.81 - 7.81) | ||
| Supportive care | 6.43 (4.53 - 9.13) | 7.48 (5.22 - 10.71) | ||
| Chemotherapy | 6.28 (3.87 - 10.20) | 6.39 (3.92 - 10.41) | ||
| Surgery + radiotherapy | 3.14 (1.99 - 4.94) | 3.54 (2.24 - 5.59) | ||
| Surgery + chemotherapy | 3.35 (1.66 - 6.77) | 3.24 (1.60 - 6.59) | ||
| Surgery + radiotherapy + chemotherapy | 3.37 (2.20 - 5.16) | 2.97 (1.94 - 4.56) |
Others, Sarcoma, Carcinosarcoma, and Melanoma; HR, Hazard ratios; CI: Confidence interval